143 related articles for article (PubMed ID: 31621389)
1. Overexpression of Long Noncoding RNA E2F-Mediated Cell Proliferation Enhancing Long Noncoding RNA Is Involved in the Development of Chemoresistance of Cancer Cells to Carboplatin in Ovarian Endometrioid Adenocarcinoma.
Zhao L; Yang J; Liu X; Fu X; Ding Y; Wang C
Cancer Biother Radiopharm; 2019 Nov; 34(9):566-571. PubMed ID: 31621389
[No Abstract] [Full Text] [Related]
2. The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation.
Wang H; Fang L; Jiang J; Kuang Y; Wang B; Shang X; Han P; Li Y; Liu M; Zhang Z; Li P
Cell Death Dis; 2018 Oct; 9(11):1103. PubMed ID: 30375398
[TBL] [Abstract][Full Text] [Related]
3. Long Non-Coding RNA (lncRNA) BMP/OP-Responsive Gene (BORG) Promotes Development of Chemoresistance of Colorectal Cancer Cells to Carboplatin.
Li J; Ma J; Zhang X; Tai X; Liu L; Zhang L
Med Sci Monit; 2020 Jan; 26():e919103. PubMed ID: 31937750
[TBL] [Abstract][Full Text] [Related]
4. The LncRNA EPEL Promotes Lung Cancer Cell Proliferation Through E2F Target Activation.
Park SM; Choi EY; Bae DH; Sohn HA; Kim SY; Kim YJ
Cell Physiol Biochem; 2018; 45(3):1270-1283. PubMed ID: 29448242
[TBL] [Abstract][Full Text] [Related]
5. LncRNA E2F-Mediated Cell Proliferation Enhancing lncRNA Regulates Cancer Cell Behaviors and Affects Prognosis of Gastric Cancer.
Fu J; Zhao W; Guo D; Li Z
Dig Dis Sci; 2020 May; 65(5):1348-1354. PubMed ID: 31584135
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of CASC11 in ovarian squamous cell carcinoma mediates the development of cancer cell resistance to chemotherapy.
Shen F; Feng L; Zhou J; Zhang H; Xu Y; Jiang R; Zhang H; Chen Y
Gene; 2019 Aug; 710():363-366. PubMed ID: 31181314
[TBL] [Abstract][Full Text] [Related]
7. LncRNA AWPPH and miRNA-21 regulates cancer cell proliferation and chemosensitivity in triple-negative breast cancer by interacting with each other.
Liu AN; Qu HJ; Gong WJ; Xiang JY; Yang MM; Zhang W
J Cell Biochem; 2019 Sep; 120(9):14860-14866. PubMed ID: 31033015
[TBL] [Abstract][Full Text] [Related]
8. Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Gregory-Bass RC; Olatinwo M; Xu W; Matthews R; Stiles JK; Thomas K; Liu D; Tsang B; Thompson WE
Int J Cancer; 2008 May; 122(9):1923-30. PubMed ID: 18183577
[TBL] [Abstract][Full Text] [Related]
9. Carboplatin-docetaxel-induced activity against ovarian cancer is dependent on up-regulated lncRNA PVT1.
Liu E; Liu Z; Zhou Y
Int J Clin Exp Pathol; 2015; 8(4):3803-10. PubMed ID: 26097562
[TBL] [Abstract][Full Text] [Related]
10. MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cells.
Zarogoulidis P; Petanidis S; Kioseoglou E; Domvri K; Anestakis D; Zarogoulidis K
Cell Signal; 2015 Aug; 27(8):1576-88. PubMed ID: 25917317
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA (LncRNA) SNHG7/ Eukaryotic translation initiation factor 4 gamma 2 (EIF4G2) involves in the malignant events of ovarian cancer cells with paclitaxel resistant.
Zhang J; Zhang R; Ye Y
Bioengineered; 2021 Dec; 12(2):10541-10552. PubMed ID: 34709112
[TBL] [Abstract][Full Text] [Related]
12. HOTAIR is a potential target for the treatment of cisplatin‑resistant ovarian cancer.
Wang Y; Wang H; Song T; Zou Y; Jiang J; Fang L; Li P
Mol Med Rep; 2015 Aug; 12(2):2211-6. PubMed ID: 25824616
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-370 suppresses proliferation and promotes endometrioid ovarian cancer chemosensitivity to cDDP by negatively regulating ENG.
Chen XP; Chen YG; Lan JY; Shen ZJ
Cancer Lett; 2014 Oct; 353(2):201-10. PubMed ID: 25063739
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations and overexpression affect prognosis of ovarian endometrioid cancer but not clear cell cancer.
Okuda T; Otsuka J; Sekizawa A; Saito H; Makino R; Kushima M; Farina A; Kuwano Y; Okai T
Gynecol Oncol; 2003 Mar; 88(3):318-25. PubMed ID: 12648581
[TBL] [Abstract][Full Text] [Related]
15. T-Type Ca2+ Channel Inhibition Sensitizes Ovarian Cancer to Carboplatin.
Dziegielewska B; Casarez EV; Yang WZ; Gray LS; Dziegielewski J; Slack-Davis JK
Mol Cancer Ther; 2016 Mar; 15(3):460-70. PubMed ID: 26832797
[TBL] [Abstract][Full Text] [Related]
16. Promotive role of recombinant HE4 protein in proliferation and carboplatin resistance in ovarian cancer cells.
Wang H; Zhu L; Gao J; Hu Z; Lin B
Oncol Rep; 2015 Jan; 33(1):403-12. PubMed ID: 25354091
[TBL] [Abstract][Full Text] [Related]
17. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
18. Circular RNA-ITCH Inhibits the Proliferation of Ovarian Carcinoma by Downregulating lncRNA HULC.
Yan H; Xiang H; Sun B; Feng F; Chen P
Reprod Sci; 2020 Jan; 27(1):375-379. PubMed ID: 32046413
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of the putative DNA/RNA helicase SLFN11 in human cancer confers resistance to platinum drugs.
Nogales V; Reinhold WC; Varma S; Martinez-Cardus A; Moutinho C; Moran S; Heyn H; Sebio A; Barnadas A; Pommier Y; Esteller M
Oncotarget; 2016 Jan; 7(3):3084-97. PubMed ID: 26625211
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of long noncoding RNA, NEAT1 promotes cell proliferation, invasion and migration in endometrial endometrioid adenocarcinoma.
Li Z; Wei D; Yang C; Sun H; Lu T; Kuang D
Biomed Pharmacother; 2016 Dec; 84():244-251. PubMed ID: 27664948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
